ALH-L1005

N/A

Report date: 2022/11/07 10:32:40

NME

Base Information

Drug NameALH-L1005

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMatrix metalloproteinase inhibitors

TargetsMatrix metalloproteinase

Therapy Area/IndicationsChronic Periodontitis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesAngiolab Inc

China Registration ClassN/A

Active CompaniesAngiolab Inc

Inactive CompaniesN/A

Active IndicationsChronic Periodontitis

Inactive IndicationsN/A

ATC CodeN/A